Anna Sankila

1.6k total citations
20 papers, 1.2k citations indexed

About

Anna Sankila is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anna Sankila has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Anna Sankila's work include Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Anna Sankila is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Anna Sankila collaborates with scholars based in Finland, United States and Switzerland. Anna Sankila's co-authors include Betania Mahler‐Araujo, Hiroko Ohgaki, Huatao Huang, Olli Kallioniemi, Tuomas Mirtti, Gieri Cathomas, Antti Rannikko, Hideki Fujii, Masanori Matsuda and Johan Lundin and has published in prestigious journals such as The EMBO Journal, Cancer Research and Oncogene.

In The Last Decade

Anna Sankila

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Sankila Finland 13 818 282 261 186 171 20 1.2k
François Ringeisen France 14 517 0.6× 305 1.1× 373 1.4× 175 0.9× 85 0.5× 33 899
Shawn Yost United States 12 477 0.6× 149 0.5× 221 0.8× 267 1.4× 210 1.2× 15 1.0k
Analía Azaro Spain 18 569 0.7× 295 1.0× 557 2.1× 198 1.1× 69 0.4× 56 1.1k
Katharina König Germany 14 564 0.7× 231 0.8× 357 1.4× 246 1.3× 121 0.7× 20 1.0k
Craig P. Giacomini United States 16 780 1.0× 324 1.1× 417 1.6× 510 2.7× 108 0.6× 18 1.3k
Margaret M. Kozak United States 19 627 0.8× 320 1.1× 758 2.9× 312 1.7× 286 1.7× 48 1.5k
Renata A. Coudry Brazil 20 587 0.7× 557 2.0× 624 2.4× 438 2.4× 192 1.1× 37 1.4k
C Lu Japan 8 1.0k 1.3× 167 0.6× 658 2.5× 270 1.5× 118 0.7× 11 1.4k
Yuehong Cui China 21 681 0.8× 370 1.3× 530 2.0× 317 1.7× 228 1.3× 79 1.4k
Carlo Gatti Italy 14 551 0.7× 112 0.4× 383 1.5× 325 1.7× 115 0.7× 30 896

Countries citing papers authored by Anna Sankila

Since Specialization
Citations

This map shows the geographic impact of Anna Sankila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sankila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sankila more than expected).

Fields of papers citing papers by Anna Sankila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sankila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sankila. The network helps show where Anna Sankila may publish in the future.

Co-authorship network of co-authors of Anna Sankila

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sankila. A scholar is included among the top collaborators of Anna Sankila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sankila. Anna Sankila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sankila, Anna, et al.. (2014). Expression of human chorionic gonadotropin in testicular germ cell tumors. Urologic Oncology Seminars and Original Investigations. 32(5). 727–734. 14 indexed citations
3.
Saeed, Khalid, Päivi Östling, Mari Björkman, et al.. (2014). Androgen receptor‐interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen‐deficient conditions. International Journal of Cancer. 136(11). 2535–2545. 9 indexed citations
4.
Zhu, Lei, Sari Jäämaa, Taija M. af Hällström, et al.. (2012). PSA forms complexes with α1‐antichymotrypsin in prostate. The Prostate. 73(2). 219–226. 23 indexed citations
5.
Sahu, Biswajyoti, Marko Laakso, Kristian Ovaska, et al.. (2011). Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. The EMBO Journal. 30(19). 3962–3976. 296 indexed citations
6.
Jäämaa, Sari, Anna Sankila, Ville Rantanen, et al.. (2011). Contrasting DNA damage checkpoint responses in epithelium of the human seminal vesicle and prostate. The Prostate. 72(10). 1060–1070. 3 indexed citations
7.
8.
Vainio, Paula, Laura Lehtinen, Tuomas Mirtti, et al.. (2011). Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins. Oncotarget. 2(12). 1176–1190. 76 indexed citations
9.
Jäämaa, Sari, Taija M. af Hällström, Anna Sankila, et al.. (2010). DNA Damage Recognition via Activated ATM and p53 Pathway in Nonproliferating Human Prostate Tissue. Cancer Research. 70(21). 8630–8641. 49 indexed citations
10.
Lönnberg, Stefan, Ahti Anttila, Laura Kotaniemi‐Talonen, et al.. (2010). Low Proportion of False-Negative Smears in the Finnish Program for Cervical Cancer Screening. Cancer Epidemiology Biomarkers & Prevention. 19(2). 381–387. 17 indexed citations
11.
Kanerva, Kristiina, et al.. (2009). High expression of antizyme inhibitor 2, an activator of ornithine decarboxylase in steroidogenic cells of human gonads. Histochemistry and Cell Biology. 132(6). 633–638. 21 indexed citations
13.
Nísen, Harry, et al.. (2008). Laparoscopic radical prostatectomy: Surgical, oncological and functional outcomes. Scandinavian Journal of Urology and Nephrology. 42(1). 29–34. 4 indexed citations
14.
Giordano, Salvatore, Seppo Taskinen, Anna Sankila, & Martti Ala‐Opas. (2008). Adenocarcinoma in isolated rectal bladder after treatment of bladder exstrophy. Scandinavian Journal of Urology and Nephrology. 42(4). 392–394. 2 indexed citations
15.
Rajecki, Maria, Anna Kanerva, Ulf‐Håkan Stenman, et al.. (2007). Treatment of prostate cancer with Ad5/3Δ24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivo. Molecular Cancer Therapeutics. 6(2). 742–751. 34 indexed citations
16.
Veijola, Lea, Anna Sankila, Hilpi Rautelin, et al.. (2006). Clinical Significance of Widespread Gastric Metaplasia in the Duodenal Bulb. Journal of Clinical Gastroenterology. 40(6). 510–514. 6 indexed citations
17.
Hotakainen, Kristina, Anders Bjartell, Anna Sankila, et al.. (2006). Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer. International Journal of Oncology. 28(1). 95–101. 22 indexed citations
18.
Oksanen, Aino, Anna Sankila, Kristina von Boguslawski, P. Sipponen, & Hilpi Rautelin. (2005). Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infection. Journal of Clinical Pathology. 58(4). 376–381. 2 indexed citations
19.
Huang, Huatao, Betania Mahler‐Araujo, Anna Sankila, et al.. (2000). APC Mutations in Sporadic Medulloblastomas. American Journal Of Pathology. 156(2). 433–437. 198 indexed citations
20.
Huang, Huatao, Hideki Fujii, Anna Sankila, et al.. (1999). β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection. American Journal Of Pathology. 155(6). 1795–1801. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026